References
1. Meazza C, Bisogno G, Gronchi A, et
al. Aggressive fibromatosis in children and adolescents: the Italian
experience. Cancer. Jan 1 2010;116(1):233-240.
2. Paul A, Blouin MJ, Minard-Colin V,
et al. Desmoid-type fibromatosis of the head and neck in children: A
changing situation. Int J Pediatr Otorhinolaryngol. Aug
2019;123:33-37.
3. Sparber-Sauer M, Seitz G, von Kalle
T, et al. Systemic therapy of aggressive fibromatosis in children and
adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe
(CWS). Pediatr Blood Cancer. May 2018;65(5):e26943.
4. Salas S, Dufresne A, Bui B, et al.
Prognostic factors influencing progression-free survival determined from
a series of sporadic desmoid tumors: a wait-and-see policy according to
tumor presentation. J Clin Oncol. Sep 10 2011;29(26):3553-3558.
5. von Mehren M, Kane JM, Bui MM, et
al. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.J Natl Compr Canc Netw. Dec 2 2020;18(12):1604-1612.
6. Desmoid Tumor Working G. The
management of desmoid tumours: A joint global consensus-based guideline
approach for adult and paediatric patients. Eur J Cancer. Mar
2020;127:96-107.
7. Gounder MM, Mahoney MR, Van Tine
BA, et al. Sorafenib for Advanced and Refractory Desmoid Tumors. N
Engl J Med. Dec 20 2018;379(25):2417-2428.
8. Colombo C, Miceli R, Le Pechoux C,
et al. Sporadic extra abdominal wall desmoid-type fibromatosis: surgical
resection can be safely limited to a minority of patients. Eur J
Cancer. Jan 2015;51(2):186-192.
9. Zhao CX, Dombrowski ND,
Perez-Atayde AR, et al. Desmoid tumors of the head and neck in the
pediatric population: Has anything changed? Int J Pediatr
Otorhinolaryngol. Jan 2021;140:110511.
10. Ratan R, Roland CL, Bishop AJ.
Desmoid Fibromatosis: Management in an Era of Increasing Options.Curr Oncol Rep. Mar 14 2021;23(4):41.
11. Martinez-Monge R, Cambeiro M,
San-Julian M, Sierrasesumaga L. Use of brachytherapy in children with
cancer: the search for an uncomplicated cure. Lancet Oncol. Feb
2006;7(2):157-166.
12. Huang MW, Zhang JG, Zheng L, Liu
SM, Yu GY. Accuracy evaluation of a 3D-printed individual template for
needle guidance in head and neck brachytherapy. J Radiat Res. Nov
2016;57(6):662-667.
13. Cox JD, Stetz J, Pajak TF.
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the
European Organization for Research and Treatment of Cancer (EORTC).Int J Radiat Oncol Biol Phys. Mar 30 1995;31(5):1341-1346.
14. Eisenhauer EA, Therasse P,
Bogaerts J, et al. New response evaluation criteria in solid tumours:
revised RECIST guideline (version 1.1). Eur J Cancer. Jan
2009;45(2):228-247.
15. Martinez Trufero J, Pajares
Bernad I, Torres Ramon I, Hernando Cubero J, Pazo Cid R. Desmoid-Type
Fibromatosis: Who, When, and How to Treat. Curr Treat Options
Oncol. May 2017;18(5):29.
16. Kasper B, Baumgarten C, Garcia J,
et al. An update on the management of sporadic desmoid-type
fibromatosis: a European Consensus Initiative between Sarcoma PAtients
EuroNet (SPAEN) and European Organization for Research and Treatment of
Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann
Oncol. Oct 1 2017;28(10):2399-2408.
17. Hoos A, Lewis JJ, Urist MJ, et
al. Desmoid tumors of the head and neck–a clinical study of a rare
entity. Head Neck. Dec 2000;22(8):814-821.
18. Miyashita H, Asoda S, Soma T, et
al. Desmoid-type fibromatosis of the head and neck in children: a case
report and review of the literature. J Med Case Rep. Jun 10
2016;10:173.
19. Nuyttens JJ, Rust PF, Thomas CR,
Jr., Turrisi AT, 3rd. Surgery versus radiation therapy for patients with
aggressive fibromatosis or desmoid tumors: A comparative review of 22
articles. Cancer. Apr 1 2000;88(7):1517-1523.
20. Risoud M, Mortuaire G, Leroy X,
Leblond P, Fayoux P. Desmoid tumours of the head and neck in children:
Review of management. Eur Ann Otorhinolaryngol Head Neck Dis. May
2017;134(3):155-160.
21. Rutenberg MS, Indelicato DJ,
Knapik JA, et al. External-beam radiotherapy for pediatric and young
adult desmoid tumors. Pediatr Blood Cancer. Sep
2011;57(3):435-442.
22. Shkalim Zemer V, Toledano H,
Kornreich L, et al. Sporadic desmoid tumors in the pediatric population:
A single center experience and review of the literature. J Pediatr
Surg. Oct 2017;52(10):1637-1641.
23. Merchant TE, Nguyen D, Walter AW,
Pappo AS, Kun LE, Rao BN. Long-term results with radiation therapy for
pediatric desmoid tumors. Int J Radiat Oncol Biol Phys. Jul 15
2000;47(5):1267-1271.
24. Fiore M, Colombo C, Radaelli S,
et al. Hormonal manipulation with toremifene in sporadic desmoid-type
fibromatosis. Eur J Cancer. Dec 2015;51(18):2800-2807.
25. Skapek SX, Anderson JR, Hill DA,
et al. Safety and efficacy of high-dose tamoxifen and sulindac for
desmoid tumor in children: results of a Children’s Oncology Group (COG)
phase II study. Pediatr Blood Cancer. Jul 2013;60(7):1108-1112.
26. Sparber-Sauer M, Orbach D, Navid
F, et al. Rationale for the use of tyrosine kinase inhibitors in the
treatment of paediatric desmoid-type fibromatosis. Br J Cancer.May 2021;124(10):1637-1646.
27. Kwon J, Lee JH, Lee YH, et al.
Whole-genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as
Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive
Fibromatosis): A Phase II Trial Study. Cancer Res Treat. Jan 17
2022.
28. Eisenstein M. The declining art
of brachytherapy. Nature. Oct 2019;574(7780):S81.
29. Chen P, Wu WJ, Yi ZQ, Ma XL, Zhao
WH, Zhang JG. (125) I interstitial brachytherapy in management of
pediatric skull base tumors. Pediatr Blood Cancer. May
2019;66(5):e27622.
30. Mao MH, Zheng L, Wang XM, et al.
Surgery combined with postoperative (125) I seed brachytherapy for the
treatment of mucoepidermoid carcinoma of the parotid gland in pediatric
patients. Pediatr Blood Cancer. Jan 2017;64(1):57-63.
31. Li J, Zhang J, Lyu XM, Huang MW,
Zheng L, Zhang JG. Efficacy of surgery combined with postoperative (125)
I interstitial brachytherapy for treatment of acinic cell carcinoma of
the parotid gland in children and adolescents. Pediatr Blood
Cancer. Jul 2020;67(7):e28343.
32. Wu WJ, Huang MW, Zhang GH, et al.
Mandibular growth in survivors of pediatric parotid gland carcinoma
treated with interstitial brachytherapy. Pediatr Blood Cancer.Sep 2018;65(9):e27223.
33. Assad WA, Nori D, Hilaris BS,
Shiu MH, Hajdu SI. Role of brachytherapy in the management of desmoid
tumors. Int J Radiat Oncol Biol Phys. Jun 1986;12(6):901-906.
34. Fontanesi J, Mott MP, Kraut MJ,
Lucas DP, Miller PR. The role of postoperative irradiation in the
treatment of locally recurrent incompletely resected extra-abdominal
desmoid tumors. Sarcoma. 2004;8(2-3):83-86.
35. Fan Y, Huang MW, Zheng L, Zhao
YJ, Zhang JG. Three-dimensional verification of (1)(2)(5)I seed
stability after permanent implantation in the parotid gland and
periparotid region. Radiat Oncol. Nov 24 2015;10:242.
36. Sundaram M, McGuire MH,
Schajowicz F. Soft-tissue masses: histologic basis for decreased signal
(short T2) on T2-weighted MR images. AJR Am J Roentgenol. Jun
1987;148(6):1247-1250.